CD19 Receptor Interactions [MoA] - N0000193544

Pharmacologic Class Information

Pharmacologic Code N0000193544
Pharmacologic Name CD19 Receptor Interactions
Pharmacologic Uses
  • CD19-directed genetically modified autologous T-cells
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD19 Receptor Interactions

The table contains 3 products whose active ingredient are classified under the same pharmacologic class CD19 Receptor Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0958Kymriah Non-Proprietary Name: TisagenlecleucelInjection, SuspensionIntravenousNovartis Pharmaceuticals CorporationACTIVE
0078-0846Kymriah Non-Proprietary Name: TisagenlecleucelInjection, SuspensionIntravenousNovartis Pharmaceuticals CorporationACTIVE
71287-119Yescarta Non-Proprietary Name: Axicabtagene CiloleucelSuspensionIntravenousKite Pharma, Inc.ACTIVE